Avstera Therapeutics Corp.
Dileep Kumar is a seasoned scientist with extensive experience in biomedical research and biotechnology. Currently serving as Principal Scientist and Team Leader at Avstera Therapeutics Inc. since January 2022, Dileep previously held the position of Principal Scientist at Advaite from December 2020 to August 2022. Dileep's prior roles include Research Scientist and Postdoctoral Associate at Huntsman Cancer Institute and University of Colorado Denver, respectively. Dileep's academic credentials include a Master of Science in Biotechnology from Jawaharlal Nehru University and a PhD in Biochemistry from the Institute of Genomics and Integrative Biology (CSIR).
This person is not in any teams
Avstera Therapeutics Corp.
Specialty oncology-focused biopharmaceutical company based in Malvern, PA with a broad pipeline encompassing novel best in class selective HDAC6i immunomodulators and a game changing myeloid based discovery platform. Avstera focuses on foundational tumor biology science, while methodologically breaking barriers using cutting-edge approaches in order to deliver impactful treatments to cancer patients.